Companies / Design Therapeutics, Inc.
Design Therapeutics, Inc.
Nasdaq: DSGNCIK 1807120CARLSBAD, CA
Financials · FY2025
Ownership
62.6M shares outstanding · as of Jul 29, 2026
Ownership
| Institutions | 64.88% | 40,603,041 |
| Public float | 35.12% | 21,978,610 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Burgess JulieChief Accounting Officer | — | — |
Gover Justin D.Director | — | — |
Jeffries SeanChief Operating Officer | — | — |
Shah PratikCEOPresident, CEO and Chairperson · Director | — | — |
Storgard ChrisChief Medical Officer | — | — |
Institutional holders 118
View all →| Holder | Value | % of shares |
|---|---|---|
| $61.22M | 10.43% | |
| $50.39M | 8.58% | |
| $38.49M | 4.25% | |
| $31.63M | 4.75% | |
| $27.51M | 4.13% | |
| $23.45M | 3.99% | |
| $15.30M | 2.61% | |
| $15.13M | 2.58% | |
| $14.36M | 2.45% | |
| $11.07M | 1.89% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jeffries Sean Executive | Grant | Stock option (right to buy) | — | +375K | 375,000 0.60% of shares | low |
| Jan 2, 2026 | Burgess Julie Executive | Grant | Stock option (right to buy) | — | +150K | 150,000 0.24% of shares | low |
| Jan 2, 2026 | Gover Justin D. Director | Grant | Stock option (right to buy) | — | +45K | 45,000 0.07% of shares | low |
| Jan 2, 2026 | Storgard Chris Executive | Grant | Stock option (right to buy) | — | +250K | 250,000 0.40% of shares | low |
| Jan 2, 2026 | Shah Pratik CEO | Grant | Stock option (right to buy) | — | +750K | 750,000 1.20% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Point72 Asset Management, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| DSGN | Common Stock | 25056L103 |